Hepatic, Renal, Hematologic, and Inflammatory Markers in HIV-Infected Children on Long-term Suppressive Antiretroviral Therapy | Zendy

Ann J. Melvin | Zendy; Meredith G. Warshaw | Zendy; Alexandra Compagnucci | Zendy; Yacine Saïdi | Zendy; Linda Harrison | Zendy; Anna Turkova | Zendy; Gareth TudorWilliams | Zendy

Open Access

Hepatic, Renal, Hematologic, and Inflammatory Markers in HIV-Infected Children on Long-term Suppressive Antiretroviral Therapy

Author(s) -

Ann J. Melvin,

Meredith G. Warshaw,

Alexandra Compagnucci,

Yacine Saïdi,

Linda Harrison,

Anna Turkova,

Gareth TudorWilliams

Publication year - 2017

Publication title -

journal of the pediatric infectious diseases society

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.269

H-Index - 31

eISSN - 2048-7207

pISSN - 2048-7193

DOI - 10.1093/jpids/pix050

Subject(s) - medicine , ritonavir , efavirenz , lopinavir , interquartile range , creatinine , gastroenterology , immunology , viral load , antiretroviral therapy , human immunodeficiency virus (hiv)

Data on long-term toxicity of antiretroviral therapy (ART) in HIV-infected children are sparse. PENPACT-1 was an open-label trial in which HIV-infected children were assigned randomly to receive protease inhibitor (PI)- or nonnucleoside reverse-transcriptase inhibitor (NNRTI)-based ART.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research